Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN14380378
ISRCTN14380378
Active, not recruiting
未知

Prospective, pragmatic study to evaluate the clinical utility of FebriDx® in determining whether or not patients presenting to a UK accident and emergency department with symptoms of acute respiratory infection require antibiotic treatment

niversity of Leeds0 sites908 target enrollmentJanuary 27, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Leeds
Enrollment
908
Status
Active, not recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 27, 2021
End Date
May 31, 2022
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Leeds

Eligibility Criteria

Inclusion Criteria

  • •1\. Participant reports a temperature of \>\=37\.5 degrees C in the last 3 days or exhibited at visit
  • •2\. Participant reports symptoms within the last 7 days that are indicative of a new, acute respiratory infection in the opinion of the research team. (Symptoms can include but are not limited to: runny nose, nasal congestion, sore throat, new cough, hoarse voice and shortness of breath).
  • •3\. Participant is aged \>\= 16 years
  • •4\. Capacity to consent
  • •5\. Ability to understand English

Exclusion Criteria

  • •1\. The participant is immunocompromised or taking chemotherapy, oral steroids, or interferon
  • •2\. The participant is currently prescribed antibiotics, antivirals or had a recent live vaccine
  • •3\. The participant has a pyrexia which has lasted more than 3 days prior to the visit to accident and emergency department

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients with Ductal Carcinoma In Situ (DCIS) Following Breast Conserving Therapy to Determine the Clinical Utility of the DCISionRT Test in the Management of DCISDuctal carcinoma in situ (DCIS) of the breastCancer - Breast
ACTRN12621000695808Prelude Australia Pty Limited1,500
Completed
Phase 2
To investigate the types of abnormal breathing patterns in patients with Motor neurone disease (MND) and to assess the usefulness of an 'intelligent' respiratory support device in patients who develop respiratory failure
ACTRN12614000794606Vinod Aiyappan40
Recruiting
Not Applicable
Observational study to assess correlation between gene present in DNA which cause fast or slow metabolism of drug (genotype), concentration of drug in blood (phenotype) and prakriti in patients on phenytoin monotherapyHealth Condition 1: null- patients who are on phenytoin monotherapy
CTRI/2011/06/001782Investigator initiated study200
Active, not recruiting
Phase 1
A Sequential, Two-Part Study to Evaluate the Clinical Benefit, Safety, Pharmacokinetics, and Pharmacodynamics of AT-007 in Pediatric Patients with Classic Galactosemia (CG)GalactosemiaMedDRA version: 20.0Level: LLTClassification code 10017610Term: GalactosemiaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
EUCTR2023-001104-33-Outside-EU/EEAApplied Therapeutics Inc.
Completed
Not Applicable
An observational study to check whether diffrernce in the carbon dioxide exhaled from two lungs can predict intraoperative fall in blood oxygen levels during elective thoracic surgeries.Health Condition 1: null- Patients undergoing elective thoracic surgeries requiring one lung ventilation with the use of double lumen tube
CTRI/2016/02/006602Tata memorial Hospital75